Therapeutic Classes/Substance P/Neurokinin-1 Receptor Antagonist

Substance P/Neurokinin-1 Receptor Antagonist

37 drugs across 17 manufacturers|35 Generic,2 Brand

The Substance P/Neurokinin-1 Receptor Antagonist class contains 37 NDCs from 17 manufacturers (35 generic, 2 brand), at an average NADAC of $68.98 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.

Total Drugs

35G / 2B

Manufacturers

Avg $68.9824/unit

Avg 7d Change

+0.23%

Across 20 drugs with changes

7d Activity

8↑12↓17 flat

of 37 total drugs

Class Price Trend

Monthly average NADAC price per unit, split by generic and brand

Manufacturer Breakdown

17 manufacturers producing drugs in this therapeutic class(1 pricing outlier)

BluePoint Laboratories

Torrent Pharmaceuticals Limited

5 drugs

$71.9180

avg/unit

Glenmark Pharmaceuticals Inc., USA

5 drugs

$71.9180

avg/unit

Merck Sharp & Dohme LLC

Hikma Pharmaceuticals USA Inc.

2 drugs

$38.5080

avg/unit

Novadoz Pharmaceuticals LLC

2 drugs

$38.5080

avg/unit

Baxter Healthcare Corporation

Camber Pharmaceuticals Inc.

1 drug

$38.5080

avg/unit

Dr. Reddy's Laboratories Inc.

1 drug

$38.5080

avg/unit

and 5 more manufacturers

Drug Portfolio

37 drugs total, 37 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Manufacturer ↕
EMEND 125 MG POWDER PACKET aprepitant	00006306603	$327.3840 per EA	—	Brand	High Outlier	Merck Sharp & Dohme LLC
EMEND 80 MG CAPSULE aprepitant	00006046102	$208.9830 per EA	—	Brand	High Outlier	Merck Sharp & Dohme LLC
APREPITANT 125 MG CAPSULE aprepitant	00781232368	$114.0440 per EA	-0.93%	Generic	—	Sandoz Inc.
APREPITANT 125 MG CAPSULE APREPITANT	13668059386	$114.0440 per EA	-0.93%	Generic	—	Torrent Pharmaceuticals Limited
APREPITANT 125 MG CAPSULE Aprepitant	68001066819	$114.0440 per EA	-0.93%	Generic	—	BluePoint Laboratories
APREPITANT 125 MG CAPSULE Aprepitant	68462058576	$114.0440 per EA	-0.93%	Generic	—	Glenmark Pharmaceuticals Inc., USA
APREPITANT 80 MG CAPSULE aprepitant	00781232246	$76.3524 per EA	-0.65%	Generic	—	Sandoz Inc.
APREPITANT 80 MG CAPSULE aprepitant	00781232268	$76.3524 per EA	-0.65%	Generic	—	Sandoz Inc.
APREPITANT 80 MG CAPSULE APREPITANT	13668059284	$76.3524 per EA	-0.65%	Generic	—	Torrent Pharmaceuticals Limited
APREPITANT 80 MG CAPSULE APREPITANT	13668059286	$76.3524 per EA	-0.65%	Generic	—	Torrent Pharmaceuticals Limited
APREPITANT 80 MG CAPSULE Aprepitant	68001066701	$76.3524 per EA	-0.65%	Generic	—	BluePoint Laboratories
APREPITANT 80 MG CAPSULE Aprepitant	68001066719	$76.3524 per EA	-0.65%	Generic	—	BluePoint Laboratories
APREPITANT 80 MG CAPSULE Aprepitant	68462058458	$76.3524 per EA	-0.65%	Generic	—	Glenmark Pharmaceuticals Inc., USA
APREPITANT 80 MG CAPSULE Aprepitant	68462058476	$76.3524 per EA	-0.65%	Generic	—	Glenmark Pharmaceuticals Inc., USA
APREPITANT 40 MG CAPSULE aprepitant	00781232106	$46.4206 per EA	+2.27%	Generic	—	Sandoz Inc.
APREPITANT 40 MG CAPSULE aprepitant	00781232151	$46.4206 per EA	+2.27%	Generic	—	Sandoz Inc.
APREPITANT 40 MG CAPSULE APREPITANT	13668059181	$46.4206 per EA	+2.27%	Generic	—	Torrent Pharmaceuticals Limited
APREPITANT 40 MG CAPSULE APREPITANT	13668059182	$46.4206 per EA	+2.27%	Generic	—	Torrent Pharmaceuticals Limited
APREPITANT 40 MG CAPSULE Aprepitant	68001066601	$46.4206 per EA	+2.27%	Generic	—	BluePoint Laboratories
APREPITANT 40 MG CAPSULE Aprepitant	68001066617	$46.4206 per EA	+2.27%	Generic	—	BluePoint Laboratories
APREPITANT 40 MG CAPSULE Aprepitant	68462058340	$46.4206 per EA	+2.27%	Generic	—	Glenmark Pharmaceuticals Inc., USA
APREPITANT 40 MG CAPSULE Aprepitant	68462058385	$46.4206 per EA	+2.27%	Generic	—	Glenmark Pharmaceuticals Inc., USA
FOSAPREPITANT 150 MG VIAL FOSAPREPITANT DIMEGLUMINE	00143938401	$38.5080 per EA	—	Generic	—	Hikma Pharmaceuticals USA Inc.
FOSAPREPITANT 150 MG VIAL FOSAPREPITANT DIMEGLUMINE	00143942801	$38.5080 per EA	—	Generic	—	Hikma Pharmaceuticals USA Inc.
FOSAPREPITANT 150 MG VIAL Fosaprepitant Dimeglumine	00338000801	$38.5080 per EA	—	Generic	—	Baxter Healthcare Corporation
FOSAPREPITANT 150 MG VIAL fosaprepitant	00591438579	$38.5080 per EA	—	Generic	—	Actavis Pharma, Inc.
FOSAPREPITANT 150 MG VIAL Fosaprepitant dimeglumine	16714024801	$38.5080 per EA	—	Generic	—	NorthStar Rx LLC
FOSAPREPITANT 150 MG VIAL Fosaprepitant dimeglumine	31722016531	$38.5080 per EA	—	Generic	—	Camber Pharmaceuticals Inc.
FOSAPREPITANT 150 MG VIAL Fosaprepitant	43598094811	$38.5080 per EA	—	Generic	—	Dr. Reddy's Laboratories Inc.
FOSAPREPITANT 150 MG VIAL FOSAPREPITANT DIMEGLUMINE	55150029901	$38.5080 per EA	—	Generic	—	Eugia US LLC
FOSAPREPITANT 150 MG VIAL FOSAPREPITANT	63323097210	$38.5080 per EA	—	Generic	—	Fresenius Kabi USA, LLC
FOSAPREPITANT 150 MG VIAL fosaprepitant	67457088910	$38.5080 per EA	—	Generic	—	Mylan Institutional LLC
FOSAPREPITANT 150 MG VIAL Fosaprepitant dimeglumine	68001052336	$38.5080 per EA	—	Generic	—	BluePoint Laboratories
FOSAPREPITANT 150 MG VIAL fosaprepitant	71839010401	$38.5080 per EA	—	Generic	—	BE Pharmaceuticals Inc.
FOSAPREPITANT 150 MG VIAL Fosaprepitant	72205005401	$38.5080 per EA	—	Generic	—	Novadoz Pharmaceuticals LLC
FOSAPREPITANT 150 MG VIAL Fosaprepitant	72205008301	$38.5080 per EA	—	Generic	—	Novadoz Pharmaceuticals LLC
FOSAPREPITANT 150 MG VIAL fosaprepitant dimeglumine	83634077610	$38.5080 per EA	—	Generic	—	Avenacy, LLC

Follow this class across the site

These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.

Top supplier

BluePoint Laboratories manufacturer profile

Review the supplier with the strongest product footprint inside this therapeutic class.

Lead market

Aprepitant market page

Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.

Trend hub

Latest trend hub

Compare this class against the rest of the weekly NADAC trend surface.

Guide

Understanding NADAC pricing

Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.

Frequently Asked Questions

How many drugs are in the Substance P/Neurokinin-1 Receptor Antagonist class?

The Substance P/Neurokinin-1 Receptor Antagonist class contains 37 NDCs from 17 manufacturers — 35 generic and 2 brand products.

What is the average price of Substance P/Neurokinin-1 Receptor Antagonist drugs?

The average NADAC for the Substance P/Neurokinin-1 Receptor Antagonist class is $68.9824 per unit across 37 NDCs.

Is generic cheaper than brand in the Substance P/Neurokinin-1 Receptor Antagonist class?

Among products priced per EA, the average generic NADAC in this class is $57.5994, versus $268.1835 for brand — brand products average about 4.7× the generic price.

Which manufacturers make Substance P/Neurokinin-1 Receptor Antagonist drugs?

17 manufacturers make drugs in the Substance P/Neurokinin-1 Receptor Antagonist class. Ranked by number of NDCs, the largest are BluePoint Laboratories (6), Sandoz Inc. (5), Torrent Pharmaceuticals Limited (5), Glenmark Pharmaceuticals Inc., USA (5), Merck Sharp & Dohme LLC (2).

How has Substance P/Neurokinin-1 Receptor Antagonist pricing changed recently?

Over the past 7 days, 8 NDCs in this class rose and 12 fell, with a class-wide average change of +0.2%.